lab-coats3

Our agile research team has miles of experience.

We treat every project as a custom project.
slide-3
Deep knowledge of pre-clinical technologies and methods.
Home 2017-07-13T05:08:14+00:00

raptr

Aragen’s RapTr™ Cell Line Development services combine the proven CHO-DG44 host cell line and vector combination with an innovative clone selection process that delivers high titers at every stage from Discovery to the Clinic.

Events

Idiopathic Pulmonary Fibrosis Summit
August 21-23, 2017 | Boston, MA

BioProcessing Summit
August 21-24, 2017 | Boston, MA

Client News

Lung Therapeutics Announces Series B Funding

BioClin Announces Series B Funding

Testimonial

…a solid performer for my company’s animal studies…
Elisabeth Gardiner, PhD Chief Scientific Officer Meditope Biosciences, Inc.

Press Releases

06.20.2017
RapTr Cell Line Development services introduced

07.11.2016
New president appointed